The Department of Health and Human Services has removed all 17 sitting members of the CDC’s Advisory Committee on Immunization Practices. More: RFK Jr.'s HHS ousts entire roster of CDC vaccine expert committee Source: fierce
read moreThe FDA has blessed Merck’s clesrovimab to protect against lower respiratory tract disease related to respiratory syncytial virus in newborns and infants. The monoclonal antibody, which will be known commercially as Enflonsia, will challenge Sanofi and AstraZeneca’s blockbuster Beyfortus. More:
read moreDespite some recent setbacks to its sickle cell disease pipeline, Pfizer is plowing ahead in improving education around the disease. More: 'Time to Listen': Pfizer debuts video series about life with sickle cell disease Source: fierce
read moreAxsome Therapeutics has hit a costly snag in its mission to bring esreboxetine to market for fibromyalgia. The FDA has refused to review the CNS specialist’s new drug application for the asset, with the agency determining that one of the
read moreAbcuro has begun to add commercial muscle ahead of the anticipated launch of an inflammatory disease drug, appointing ex-Priovant Therapeutics executive Courtney Cupples to its C-suite to lead preparations. More: Abcuro hires ex-Alexion, Biohaven exec to lead commercial team ahead
read more© 1994 - 2025 B.M. Pharmaceuticals